Unknown

Dataset Information

0

A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy in unresectable locally advanced non-small cell lung cancer

ABSTRACT:

SUBMITTER: Zhang H 

PROVIDER: S-EPMC12337057 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Predicting radiation pneumonitis with dose-segmented radiomics in locally advanced non- small cell lung cancer patients undergoing consolidative immunotherapy post- concurrent chemoradiotherapy.
| S-EPMC12510859 | biostudies-literature
Unknown Immunotherapy combined with definitive chemoradiotherapy for locally advanced unresectable esophageal squamous cell carcinoma.
| S-EPMC12518077 | biostudies-literature
Unknown Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients.
| S-EPMC7901487 | biostudies-literature
Unknown Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
| S-EPMC9706919 | biostudies-literature
Unknown Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma.
| S-EPMC7871351 | biostudies-literature
Unknown Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma.
| S-EPMC5514892 | biostudies-literature
Unknown Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
| S-EPMC5870479 | biostudies-literature
Unknown Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
| S-EPMC6491187 | biostudies-literature
Unknown Induction chemotherapy administration increases the risk of radiation pneumonitis in unresectable stage III NSCLC patients undergoing concurrent chemoradiotherapy with immunotherapy.
| S-EPMC12924971 | biostudies-literature
Unknown Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.
| S-EPMC12477293 | biostudies-literature